236 related articles for article (PubMed ID: 25908026)
41. Increased gene dosage of the Ink4/Arf locus does not attenuate atherosclerosis development in hypercholesterolaemic mice.
Fuster JJ; Molina-Sánchez P; Jovaní D; Vinué Á; Serrano M; Andrés V
Atherosclerosis; 2012 Mar; 221(1):98-105. PubMed ID: 22226369
[TBL] [Abstract][Full Text] [Related]
42. The role of junctional adhesion molecule-C (JAM-C) in oxidized LDL-mediated leukocyte recruitment.
Keiper T; Al-Fakhri N; Chavakis E; Athanasopoulos AN; Isermann B; Herzog S; Saffrich R; Hersemeyer K; Bohle RM; Haendeler J; Preissner KT; Santoso S; Chavakis T
FASEB J; 2005 Dec; 19(14):2078-80. PubMed ID: 16195363
[TBL] [Abstract][Full Text] [Related]
43. Deletion of tenascin-C gene exacerbates atherosclerosis and induces intraplaque hemorrhage in Apo-E-deficient mice.
Wang L; Wang W; Shah PK; Song L; Yang M; Sharifi BG
Cardiovasc Pathol; 2012; 21(5):398-413. PubMed ID: 22300502
[TBL] [Abstract][Full Text] [Related]
44. Activation of AMP-activated protein kinase is required for berberine-induced reduction of atherosclerosis in mice: the role of uncoupling protein 2.
Wang Q; Zhang M; Liang B; Shirwany N; Zhu Y; Zou MH
PLoS One; 2011; 6(9):e25436. PubMed ID: 21980456
[TBL] [Abstract][Full Text] [Related]
45. Thrombin stimulates human endothelial arginase enzymatic activity via RhoA/ROCK pathway: implications for atherosclerotic endothelial dysfunction.
Ming XF; Barandier C; Viswambharan H; Kwak BR; Mach F; Mazzolai L; Hayoz D; Ruffieux J; Rusconi S; Montani JP; Yang Z
Circulation; 2004 Dec; 110(24):3708-14. PubMed ID: 15569838
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of Local Macrophage Growth Ameliorates Focal Inflammation and Suppresses Atherosclerosis.
Yamada S; Senokuchi T; Matsumura T; Morita Y; Ishii N; Fukuda K; Murakami-Nishida S; Nishida S; Kawasaki S; Motoshima H; Furukawa N; Komohara Y; Fujiwara Y; Koga T; Yamagata K; Takeya M; Araki E
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):994-1006. PubMed ID: 29496659
[TBL] [Abstract][Full Text] [Related]
47. Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice.
Danzaki K; Matsui Y; Ikesue M; Ohta D; Ito K; Kanayama M; Kurotaki D; Morimoto J; Iwakura Y; Yagita H; Tsutsui H; Uede T
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):273-80. PubMed ID: 22116098
[TBL] [Abstract][Full Text] [Related]
48. Cholesterol effects on endoglin and its downstream pathways in ApoE/LDLR double knockout mice.
Strasky Z; Vecerova L; Rathouska J; Slanarova M; Brcakova E; Kudlackova Z; Andrys C; Micuda S; Nachtigal P
Circ J; 2011; 75(7):1747-55. PubMed ID: 21576826
[TBL] [Abstract][Full Text] [Related]
49. oxLDL induces endothelial cell proliferation via Rho/ROCK/Akt/p27
Zhang C; Adamos C; Oh MJ; Baruah J; Ayee MAA; Mehta D; Wary KK; Levitan I
Am J Physiol Cell Physiol; 2017 Sep; 313(3):C340-C351. PubMed ID: 28701359
[TBL] [Abstract][Full Text] [Related]
50. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW
Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843
[TBL] [Abstract][Full Text] [Related]
51. TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice.
Wu C; He S; Peng Y; Kushwaha KK; Lin J; Dong J; Wang B; Lin J; Shan S; Liu J; Huang K; Li D
J Mol Cell Cardiol; 2014 Nov; 76():33-45. PubMed ID: 25117469
[TBL] [Abstract][Full Text] [Related]
52. BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis.
Singh KK; Shukla PC; Quan A; Al-Omran M; Lovren F; Pan Y; Brezden-Masley C; Ingram AJ; Stanford WL; Teoh H; Verma S
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):949-960.e4. PubMed ID: 23415688
[TBL] [Abstract][Full Text] [Related]
53. PKC-β activation inhibits IL-18-binding protein causing endothelial dysfunction and diabetic atherosclerosis.
Durpès MC; Morin C; Paquin-Veillet J; Beland R; Paré M; Guimond MO; Rekhter M; King GL; Geraldes P
Cardiovasc Res; 2015 May; 106(2):303-13. PubMed ID: 25808972
[TBL] [Abstract][Full Text] [Related]
54. Endothelial and macrophage-specific deficiency of P38α MAPK does not affect the pathogenesis of atherosclerosis in ApoE-/- mice.
Kardakaris R; Gareus R; Xanthoulea S; Pasparakis M
PLoS One; 2011; 6(6):e21055. PubMed ID: 21695272
[TBL] [Abstract][Full Text] [Related]
55. CD146 deficiency promotes plaque formation in a mouse model of atherosclerosis by enhancing RANTES secretion and leukocyte recruitment.
Blin MG; Bachelier R; Fallague K; Moussouni K; Aurrand-Lions M; Fernandez S; Guillet B; Robert S; Foucault-Bertaud A; Bardin N; Blot-Chabaud M; Dignat-George F; Leroyer AS
J Mol Cell Cardiol; 2019 May; 130():76-87. PubMed ID: 30928429
[TBL] [Abstract][Full Text] [Related]
56. Rapamycin regulates endothelial cell migration through regulation of the cyclin-dependent kinase inhibitor p27Kip1.
Moss SC; Lightell DJ; Marx SO; Marks AR; Woods TC
J Biol Chem; 2010 Apr; 285(16):11991-7. PubMed ID: 20097763
[TBL] [Abstract][Full Text] [Related]
57. Cyclic GMP kinase and RhoA Ser188 phosphorylation integrate pro- and antifibrotic signals in blood vessels.
Sawada N; Itoh H; Miyashita K; Tsujimoto H; Sone M; Yamahara K; Arany ZP; Hofmann F; Nakao K
Mol Cell Biol; 2009 Nov; 29(22):6018-32. PubMed ID: 19737918
[TBL] [Abstract][Full Text] [Related]
58. ADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in mice.
Gandhi C; Khan MM; Lentz SR; Chauhan AK
Blood; 2012 Mar; 119(10):2385-91. PubMed ID: 22123843
[TBL] [Abstract][Full Text] [Related]
59. Dasatinib inhibits actin fiber reorganization and promotes endothelial cell permeability through RhoA-ROCK pathway.
Dasgupta SK; Le A; Vijayan KV; Thiagarajan P
Cancer Med; 2017 Apr; 6(4):809-818. PubMed ID: 28316141
[TBL] [Abstract][Full Text] [Related]
60. Rapamycin attenuates atherosclerosis induced by dietary cholesterol in apolipoprotein-deficient mice through a p27 Kip1 -independent pathway.
Castro C; Campistol JM; Sancho D; Sánchez-Madrid F; Casals E; Andrés V
Atherosclerosis; 2004 Jan; 172(1):31-8. PubMed ID: 14709354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
